More concern about transfusion requirement when evaluating quality of life in anemic patients [5] (mutiple letters)

Journal of Clinical Oncology

Volumn 20, Issue 14, 2002, Pages 3182-3184

  Oliva, Esther N ^a   D'Angelo, Arianna ^a   Martino, Bruno ^a   Nobile, Francesco ^a   Dimitrov, Borislav D ^a   Perna, Annalisa ^a   Gabrilove, Janice L ^a   Sarokhan, Brenda ^a   Cremieux, Pierre ^a  

^a MA

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN; RECOMBINANT ERYTHROPOIETIN;

ANEMIA; BLOOD TRANSFUSION; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; FUNCTIONAL ASSESSMENT; HUMAN; LETTER; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; QUALITY OF LIFE; TREATMENT OUTCOME; TREATMENT PLANNING; WELLBEING;

EID: 0037099753     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2002.20.14.3182     Document Type: Letter

References (0)